Industry snapshot
Key public data points
Historical & forecast
Base year 2025. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2030.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the Eye Surgery Clinics in the US industry cover?
The industry comprises clinical facilities and freestanding outpatient surgical suites dedicated to diagnosing, managing, and surgically treating optical disorders. These specialized clinics focus on highly common procedures that do not require overnight hospital stays, optimizing patient throughput and comfort.
- •Primary services include laser vision correction (LASIK), corneal transplants, glaucoma management, and vitreoretinal interventions.
- •A substantial volume of industry activity is centered on cataract procedures, which have steadily migrated from hospitals to dedicated clinical settings.
- •Most operations are classified under government codes designating freestanding outpatient care or physician offices.
Market Structure and Operators
Who operates in the industry and how is it structured?
The US eye surgery clinic sector is highly fragmented but undergoing rapid corporatization through private equity roll-ups and regional clinic networks. While thousands of independent ophthalmology practices exist, large management platforms are consolidating operations to gain administrative efficiencies and negotiating leverage with private insurers.
- •According to MedPAC, over 95 percent of all Medicare-certified ASCs are operated on a for-profit basis.
- •As of 2024, approximately 94 percent of these surgical facilities are situated in highly populated urban areas.
- •Consolidation is rising, with the top five corporate clinical operators increasing their ownership stake across the broader outpatient surgery sector to 21.5 percent of all facilities by 2024.
Demand Drivers
What drives demand in the industry?
Demographic shifts represent the primary tailwind for ophthalmic surgery clinics, as age-related eye conditions scale exponentially with the aging Baby Boomer cohort. Furthermore, public and private payers are aggressively incentivizing outpatient migration to reduce systemic healthcare costs.
- •In 2023, extracapsular cataract removal with lens insertion accounted for approximately 19 percent of all ASC fee-for-service Medicare volume and spending.
- •Medicare fee-for-service program and beneficiary spending on outpatient ASC services escalated to approximately $7.5 billion in 2024.
- •Medicare reimbursement structures heavily favor clinics over hospitals, paying ASCs an average of only 62 percent of hospital outpatient department rates for identical procedures.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
Competition in the eye surgery space is characterized by local market density, clinical reputations, and strategic geographic partnerships with major healthcare systems. Key industry participants include both diversified healthcare operators and pure-play ophthalmic clinic platforms.
- •Surgery Partners, Inc. is a major publicly traded operator with over 300 surgical facilities spanning 30 states, including a large portfolio of ophthalmic clinics.
- •AMSURG is a highly prominent national operator managing dozens of dedicated ophthalmic surgical centers across the US.
- •EyeCare Partners, LLC and Retina Consultants of America represent massive private-equity-backed clinical networks leading consolidation in general ophthalmology and specialized retina care respectively.
- •Unifeye Vision Partners and Eye Health America are rapidly expanding regional clinical platforms focusing heavily on state-of-the-art ambulatory surgical facilities.
Recent Trends and Outlook
What are the recent trends and outlook?
The industry is benefiting from technological advancements that reduce recovery times and expand the range of treatable conditions in an office or ASC setting. Premium intraocular lenses (IOLs) and advanced femtosecond lasers are increasingly adopted, allowing clinics to capture lucrative out-of-pocket, private-pay revenue.
- •Outpatient surgery volume per Medicare beneficiary experienced a 3.5 percent year-over-year increase in 2024.
- •The number of operating ASCs nationwide expanded at a steady clip of over 2 percent annually between 2019 and 2024.
- •Total Medicare savings generated by migrating procedures to ASCs are projected to reach $84.8 billion over the 2025-2034 period.
Regulation and Compliance
How is the industry regulated?
Eye surgery clinics operate under stringent regulatory oversight regarding patient safety, facility sterilization, and professional licensing. Compliance is governed at both federal and state levels, with reimbursement rates heavily dependent on annual adjustments enacted by the federal government.
- •Facilities must maintain active certification from the Centers for Medicare & Medicaid Services (CMS) to receive federal program reimbursements.
- •Clinics are heavily impacted by the annual Medicare Physician Fee Schedule and the ASC Payment System updates issued by CMS.
- •State-level Certificate of Need (CON) regulations in various jurisdictions restrict the arbitrary opening of new competing surgical centers, acting as a barrier to entry.
Sources
Government, statistical and trade sources used for this Claight analysis.
- Medicare Payment Advisory Commission (MedPAC) March 2026 Report to Congress ·
- Medicare Payment Advisory Commission (MedPAC) March 2025 Report to Congress ·
- Ambulatory Surgery Center Association (ASCA) 2024 Report
Claight analysis of public industry data.